186 related articles for article (PubMed ID: 11786399)
21. Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.
Shen L; Kondo Y; Ahmed S; Boumber Y; Konishi K; Guo Y; Chen X; Vilaythong JN; Issa JP
Cancer Res; 2007 Dec; 67(23):11335-43. PubMed ID: 18056460
[TBL] [Abstract][Full Text] [Related]
22. Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.
Gutierrez MI; Siraj AK; Bhargava M; Ozbek U; Banavali S; Chaudhary MA; El Solh H; Bhatia K
Leukemia; 2003 Sep; 17(9):1845-50. PubMed ID: 12970785
[TBL] [Abstract][Full Text] [Related]
23. Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas.
Ohta T; Watanabe T; Katayama Y; Yoshino A; Yachi K; Ogino A; Komine C; Fukushima T
Oncol Rep; 2006 Nov; 16(5):957-63. PubMed ID: 17016577
[TBL] [Abstract][Full Text] [Related]
24. CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients.
Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; Amiñoso C; de Campos JM; Sarasa JL; Gutierrez M; Rey JA
Cancer Genet Cytogenet; 2003 Apr; 142(1):21-4. PubMed ID: 12660028
[TBL] [Abstract][Full Text] [Related]
25. Alteration of p73 in pediatric de novo acute lymphoblastic leukemia.
Sahu GR; Das BR
Biochem Biophys Res Commun; 2005 Feb; 327(3):750-5. PubMed ID: 15649410
[TBL] [Abstract][Full Text] [Related]
26. Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation.
Liu M; Taketani T; Li R; Takita J; Taki T; Yang HW; Kawaguchi H; Ida K; Matsuo Y; Hayashi Y
Leuk Res; 2001 Jun; 25(6):441-7. PubMed ID: 11337015
[TBL] [Abstract][Full Text] [Related]
27. [Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome].
Zhao YS; Yang R; Gu SC; Guo J; Zhang X; Wu LY; Li X; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):847-51. PubMed ID: 23384909
[TBL] [Abstract][Full Text] [Related]
28. The association between non-Hodgkin lymphoma and methylation of p73.
Pei JH; Luo SQ; Zhong Y; Chen JH; Xiao HW; Hu WX
Tumour Biol; 2011 Dec; 32(6):1133-8. PubMed ID: 21811875
[TBL] [Abstract][Full Text] [Related]
29. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation.
Kawano S; Miller CW; Gombart AF; Bartram CR; Matsuo Y; Asou H; Sakashita A; Said J; Tatsumi E; Koeffler HP
Blood; 1999 Aug; 94(3):1113-20. PubMed ID: 10419905
[TBL] [Abstract][Full Text] [Related]
30. DNA hypermethylation status of multiple genes in prostate adenocarcinomas.
Konishi N; Nakamura M; Kishi M; Nishimine M; Ishida E; Shimada K
Jpn J Cancer Res; 2002 Jul; 93(7):767-73. PubMed ID: 12149142
[TBL] [Abstract][Full Text] [Related]
31. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
32. Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.
Weaver KD; Grossman SA; Herman JG
Cancer Invest; 2006 Feb; 24(1):35-40. PubMed ID: 16466990
[TBL] [Abstract][Full Text] [Related]
33. Aberration of p73 promoter methylation in de novo myelodysplastic syndrome.
Zhao Y; Gu S; Guo J; Zhang Z; Zhang X; Li X; Chang C
Hematology; 2012 Sep; 17(5):275-82. PubMed ID: 22971533
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies.
Nakatsuka S; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Yamaguchi M; Nishii K; Yang WI; Aozasa K
Cancer Sci; 2003 Jan; 94(1):87-91. PubMed ID: 12708480
[TBL] [Abstract][Full Text] [Related]
35. Mouse p73 gene maps to the distal part of chromosome 4 and might be involved in the progression of gamma-radiation-induced T-cell lymphomas.
Herranz M; Santos J; Salido E; Fernández-Piqueras J; Serrano M
Cancer Res; 1999 May; 59(9):2068-71. PubMed ID: 10232589
[TBL] [Abstract][Full Text] [Related]
36. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
[TBL] [Abstract][Full Text] [Related]
37. Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia.
Hatzimichael E; Benetatos L; Dasoula A; Dranitsaris G; Tsiara S; Georgiou I; Syrrou M; Stebbing J; Coley HM; Crook T; Bourantas KL
Leuk Res; 2009 Sep; 33(9):1272-5. PubMed ID: 19423161
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients.
Kim JW; Park HM; Choi YK; Chong SY; Oh D; Kim NK
Oncol Rep; 2011 Jan; 25(1):167-72. PubMed ID: 21109973
[TBL] [Abstract][Full Text] [Related]
39. 5-Aza-2'-deoxycytidine increases the sensitivity of human bone marrow mesenchymal stem cells to chemotherapeutic agents by demethylation of p73.
Liang W; Xia H; Li J; Chunhua Zhao R
J Pediatr Hematol Oncol; 2012 Mar; 34(2):108-15. PubMed ID: 22278203
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
